Matthias Gossmann | Managing Director
InnoVitro

Matthias Gossmann, Managing Director, InnoVitro

Dr. rer. nat. Dipl. Ing. Matthias Goßmann holds a diploma in biotechnology and a doctorate degree in chemistry. Since 2008, he has been working on the development of a new technology to measure cardiac contraction force within a flexible environment. He gained 3.5 years of experience as senior scientist in the stem cell industry, before starting his own business as one of the two founders of innoVitro, in 2017. innoVitro’s main focus is the product of his doctorate degree project: The FLEXcyte 96 Service, a cardiac contractility assay co-developed with Nanion Technologies.

Appearances:



Conference Day 2 - Wednesday 1st April 2020 @ 15:00

FLEXcyte 96 "A new technology to evaluate mature cardiac contractility on high throughput level"

  • Improved drug development process
  • Physiological & flexible cardiac environment
  • High throughput mature cardiac contractility service
last published: 04/Jun/20 08:25 GMT

back to speakers